Abstract
A study was undertaken to clarify the usefulness of two cationic dyes, alcian blue (AB) and ruthenium red (RR) in demonstrating the defect in cellular membranes noted in minimal change nephropathy (MCN). The binding of both dyes to RBC membranes purified from normal and nephrotic children was evaluated by electrophoretic titration curves. When examined separately, AB was found to precipitate spontaneously, producing macro-aggregates with no electrophoretic mobility at pH 5. This was presumed to be the result of hydrophobic interaction of the dye with itself. The same phenomenon was observed when this dye was incubated at 37°C with RBC ghost's from normal children, when AB presented a sigmoidal curve with a net positive charge for pHs higher than 5.5 and lower than 5 and no electrophoretic mobility at pH 5. However, incubation of AB with RBC ghosts from children with MCN resulted in an improvement of the solubility of the dye which then migrated with a net positive charge along the whole gradient of pH from 3.5 to 9. The presence of zwitterionic neutral detergents such as CHAPS, but not of a charged substance such as protamine sulphate, inhibited precipitation at pH 5 when incubated with membranes from normal children, supporting the hydrophobic nature of the phenomenon. When RR was used instead of AB, it was fully protonated (i.e. did not precipitate) when analysed alone, but when incubated with normal RBC ghosts, it also revealed no electrophoretic mobility at pH 5. Likewise, as seen with AB, the incubation of RR with RBC ghosts from children with MCN or with zwitterionic detergents produced an improvement in the ionization of the dye. We conclude that RBC membranes purified from children with MCN improved the solubility of AB in aqueous media by inhibiting the hydrophobic interaction of the dye, and the same explanation may hold true for the improved solubility noted with the use of RR under similar conditions. The identification of the membrane factor(s) which is responsible for this effect may be relevant to the understanding of any cellular membrane alteration in the glomeruli of children with MCN.
Similar content being viewed by others
References
Caulfield JP, Farquhar MG (1976) Distribution of anionic sites in glomerular basement membranen. Their possible role in filtration and attachment. Proc Natl Acad Sci USA 73: 1646–1650
Hunsicker LG, Shearer TP, Shaffer SJ (1981) Acute reversible proteinuria induced by infusion of the polycation hexadimethrine. Kidney Int 20: 7–17
Vehaskari VM, Root ER, Germuth FG, Robson AM (1982) Glomerular charge and urinary protein excretion: effects of systemic and intrarenal polycation infusion in the rat. Kidney Int 22: 127–135
Rennke HG, Venkathachalam MA (1977) Glomerular permeability: in vivo tracer study with polyanionic and polycationic ferritins. Kidney Int 11: 44–53
Carrie BJ, Salyer WR, Myers BD (1981) Minimal change nephropathy: an electrochemical disorder of glomerular membrane. Am J Med 70: 262–268
Bridges CR, Myers BD, Brenner BM, Deen WM (1982) Glomerular charge alterations in human minimal change nephropathy. Kidney Int 22: 677–684
Ghiggeri GM, Candiano G, Ginevri F, Gusmano R, Ciardi MR, Perfumo F, Delfino G, Cuniberti C, Queirolo C (1987) Renal selectivity towards endogenous albumin in minimal change nephropathy. Kidney Int 32: 69–77
Levin M, Smith C, Walters MDS, Gascoine P, Barratt TM (1985) Steroid responsive nephrotic syndrome: a generalized disorder of negative charge. Lancet I: 239–242
Boulton-Jones JM, McWilliams G, Chandrachud L (1986) Variation in charge on red cells of patients with different nephropathies. Lancet II: 186–188
Gambaro G, Baggio B, Cicerello E, Mastrosimone S, Marzaro G, Borsatti A, Crepaldi G (1988) Abnormal erythrocyte charge in diabetes mellitus. Diabetes 37: 745–748
Bernard AM, Ouled Amor A, Lauwerys RR (1988) Decrease of erythrocyte and glomerular membrane negative charges in chronic cadmium poisoning. Br J Ind Med 45: 112–115
Mutti A, Bergamaschi E, Ghiggeri GM, Righetti PG, Spaggiari M, Alinovi R, Candiano G, Franchini I (1989) What is measured by the alcian blue binding to red blood cells. Br J Ind Med 46: 286–287
Sewell RF, Brenchly PEC (1986) Red-cell surface in glomerular disease. Lancet II: 635–636
Fechally J, Samanta A, Kinghorn H, Burden AC, Walls J (1986) Red-cell surface charge in glomerular disease. Lancet II: 635
Ghiggeri GM, Candiano G, Ginevri F, Mutti A, Bergamaschi E, Alinovi R, Righetti PG (1988) Hydrophobic interactions of Alcian blue with soluble and erythrocyte membrane proteins. J Chromatogr 452: 347–357
International Study of Kidney Disease in Children (1978) The nephrotic syndrome in children. Prediction of histopathology from clinical and laboratory characteristics at the time of diagnosis. Kidney Int 13: 160–166
Dodge JT, Mitchell C, Hanahan DJ (1964) The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 100: 119–130
Bianchi-Bosisio A, Loeherlein C, Snyder RS, Righetti PG (1980) Titration curves of proteins by combined isoelectric focusing—electrophoresis in highly porous polyacrylamide matrices. J Chromatogr 189: 317–330
Righetti PG, Gianazza E (1979) pH-mobility curves of proteins by isoelectric focusing combined with electrophoresis at right angels. In: Radola BJ (ed) “Electrophoresis 79”. de Gruyter, Berlin, pp 23–38
Cohen HT, Singh AK, Kasinath BS, Lewis EJ (1988) Red cell surface charge in patients with nephrotic syndrome. Lancet I: 1459
Ginevri F, Ghiggeri GM, Candiano G, Oleggini R, Bertelli R, Piccardo MT, Perfumo F, Gusmano R (1989) Peroxidative damage of the erythrocyte membrane in children with nephrotic syndrome. Pediatr Nephrol 3: 25–32
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Candiano, G., Ghiggeri, G.M., Oleggini, R. et al. Interaction between cationic dyes and erythrocyte membranes in minimal change nephropathy: an electrophoretic approach. Pediatr Nephrol 5, 173–178 (1991). https://doi.org/10.1007/BF01095945
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01095945